{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Ftreatment-of-skin-and-soft-tissue-infections-loixSbCG","width":444,"version":"1.0","type":"rich","title":"Treatment of Skin and Soft Tissue Infections","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/dc7c09c1-61de-489d-8f08-99d6a956a195/674b04bf-ec5d-40a8-986f-d5dd39cdc276/lal-absssi-mm-pod2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2ef6ea5a-d70e-412d-97f8-597f69839d54\" height=\"200\" width=\"100%\" title=\"Treatment of Skin and Soft Tissue Infections\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as Kyle Molina, PharmD, BCIDP, discusses guideline recommendations for treatment of both purulent and nonpurulent skin and soft tissue infections, challenges with IV and oral antibiotics, and the role of long-acting lipoglycopeptides in the treatment landscape"}